A new review warns that the molecular tests defining modern glioma diagnosis remain out of reach for most of the world, and ...

Children diagnosed with diffuse midline gliomas often die within a year after their initial diagnosis since there are no effective treatments yet for this rare cancer. But researchers now have a ...

Cancer is a sneaky disease. Find one method of treating it successfully, and it finds another way to survive. Take, for example, pediatric diffuse midline gliomas, brain tumors that are among the most ...

Modeyso is the first FDA-approved systemic therapy for H3 K27M-mutant diffuse midline glioma, targeting both adult and pediatric patients. Clinical trials demonstrated a 22% overall response rate with ...

Newswise — The treatment of adult diffuse glioma faces numerous challenges. Although detailed studies on its genomic alterations are underway, subtype-specific susceptibilities remain unclear, making ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Hypofractionated radiation therapy with concurrent and adjuvant temozolomide is conditionally recommended for elderly patients. HealthDay News — In a clinical practice guideline issued by the American ...

Newswise — ARLINGTON, Va., June 26, 2025 — A new clinical guideline from the American Society for Radiation Oncology (ASTRO) focuses on the use of radiation therapy to treat adult patients with World ...

Historical standards for H3 K27M–mutant diffuse midline glioma treatment may harm healthy central nervous system cells, according to Ashley L. Sumrall, MD. Sumrall, a neuro-oncologist at Atrium Health ...

Historical standards for H3K27M-mutant diffuse midline glioma treatment may harm healthy central nervous system cells, according to Ashley L. Sumrall, MD. The FDA approval of dordaviprone (Modeyso) in ...